基本信息:
- 专利标题： COMPOSITIONS AND METHODS FOR TREATING COVID-19
- 申请号：PCT/US2021/037747 申请日：2021-06-17
- 公开(公告)号：WO2021257781A1 公开(公告)日：2021-12-23
- 发明人： LAI, Norman Zhennan , TAN, Yuebin , WANG, Ying
- 申请人： VAST SEA BIOTECHNOLOGY, INC.
- 申请人地址： 9605 Medical Center Drive
- 专利权人： VAST SEA BIOTECHNOLOGY, INC.
- 当前专利权人： VAST SEA BIOTECHNOLOGY, INC.
- 当前专利权人地址： 9605 Medical Center Drive
- 代理机构： GROLZ, Edward W.
- 优先权： US63/041,587 2020-06-19
- 主分类号： A61P31/14
- IPC分类号： A61P31/14 ; C07K14/165 ; C12N15/50 ; G01N33/569 ; A23L33/18 ; A23V2002/00 ; A61K31/198 ; A61K31/375 ; A61K31/4415 ; A61K31/593 ; A61K31/7088 ; A61K31/714 ; A61K33/30 ; A61K36/534 ; A61K38/4813 ; A61K48/00 ; C12N15/1131 ; C12N15/86 ; C12N2310/14 ; C12N2310/321 ; C12N2310/322 ; C12N2310/3517 ; C12N2320/32 ; C12N2750/14143 ; C12Y304/17023
摘要：
This disclosure is directed to inhibitory oligonucleotides, inhibitory peptides, compositions and methods for preventing or treating Coronavirus disease 2019 (COVID-19). In one aspect, the disclosure is directed to compositions that comprise inhibitory oligonucleotides against one or more SARS-CoV-2 virus genes. In another aspect, the disclosure is directed to compositions that comprise inhibitory peptides that inhibit SARS-COV-2 entry into cells. Another aspect of the disclosure is directed to gene therapy methods for treating COVID-19, and vectors for carrying out the same. Finally, the disclosure provides nutritional supplements to support human immunity and prevent or inhibit viral infections.
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61P | 化合物或药物制剂的治疗活性 |
| ------A61P31/00 | 抗感染药，即抗生素、抗菌剂、化疗剂 |
| --------A61P31/12 | .抗病毒剂 |
| ----------A61P31/14 | ..用于RNA病毒的 |